Be sure to join the Brandwood Biomedical team at the upcoming RAPS Regulatory Convergence 2017 commencing September 9 through to September 12. Be sure to drop by booth 404 to meet our CEO Grant Bennett, Founder Arthur Brandwood, Principal Health Economist Sarah Griffin and our Pharma Consulting Partner Rob Stringer of Capital K.
Also be sure to check out our informative session being held on the Navigation of Type Testing and Clinical Evidence Expectations in China. The session aims to provide first-hand experience in gaining approvals for IVDs in China. The session will include the testing requirements, what’s expected of a clinical trial, clinical evidence and most importantly, how to get the product approved.
For more details on this event, click here.
We’re looking forward to seeing you there!